Author

A. L. Cox

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. A. R. Tobian· 1 shared A. L. Mammen· 1 shared A. N. Baer· 1 shared A. Suhrbier· 1 shared A. Wilbon· 1 shared A. Z. Rosenberg· 1 shared B. Parekkadan· 1 shared B. Tang· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. A. R. Tobian

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neurovirulence of the Australian outbreak Japanese Encephalitis virus genotype 4 is lower compared to genotypes 2 and 3 in mice and human cortical brain organoids

W. Nguyen, N. Gyawali, R. Stewart, B. Tang, A. L. Cox, K. Yan, T. Larcher, C. R. Bishop, N. Wood, G. Devine, A. Suhrbier, D. J. Rawle

This study compares the neurovirulence of JEV genotype 4 (JEVNSW/22) with genotypes 2 and 3 in mice and human brain organoids, finding JEVNSW/22 less neurovirulent and more sensitive to type I interferon.

bioRxiv · Apr 26, 2023 · PreprintMicrobiology

Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly

J. J. Credle, J. Gunn, P. Sangkhapreecha, D. R. Monaco, X. A. Zheng, H.-J. Tsai, A. Wilbon, W. R. Morgenlander, Y. Dong, S. Jayaraman, L. Tosi, B. Parekkadan, A. N. Baer, M. Roederer, E. M. Bloch, , H. B. Larman

MIPSA identifies neutralizing IFNL3 autoantibodies in severe COVID-19 patients by profiling autoantibodies against DNA-barcoded proteins.

bioRxiv · Mar 2, 2021 · PreprintImmunology